To the best of our knowledge, this is the first meta-analysis examining the effect of UGT1A1*28 polymorphism on the risk of hyperbilirubinemia in HIV-positive patients receiving ATV. The gene discussed is UGT1A1; the disease is Hyperbilirubinemia.